Evotec Appoints Rui Wang as Head of Global In Silico and AI
HAMBURG, DE / ACCESS Newswire / June 2, 2026 / Evotec SE (NASDAQ:EVO)(Frankfurt Prime Standard:EVT) today announced the appointment of...
Neurology
Privia Health Enters New Jersey
Represents 25th State in National Primary Care-Centric Care Delivery NetworkARLINGTON, Va., May 27, 2026 (GLOBE NEWSWIRE) -- Privia Health Group,...
Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease
SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) -- Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of...
Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy
– Alterity’s novel imaging and biomarker approach positions the Company at the forefront of clinical research in MSA – –...
Organon to Present New Research on Access and Value at ISPOR 2026
New findings will highlight contraception affordability, biosimilar adoption, and access-focused analyses across the women’s health and general medicines portfolioJERSEY CITY,...
CNS Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Strategic Transformation Progress
Oversubscribed $22.5 million financing anticipated to enable CNS Pharmaceuticals to acquire differentiated, clinical-stage assets with identifiable near-term value-inflection catalysts, aligned...
argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
VYVGART and VYVGART Hytrulo are the first and only approved treatments for all serotypes of adult patients living with gMG...
Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall
Joint Evotec-Almirall team advances small molecule program to preclinical development significantly outperforming standard industry timelinesCollaboration leverages Evotec's end-to-end integrated AI/ML-driven...
Evotec Receives Grants to Advance Tuberculosis Treatment
Grants support discovery and development of novel drug candidates and evaluation and prioritization of advanced drug regimens for clinical testingNew...
Evotec SE to Announce First Quarter 2026 Results on May 6, 2026
HAMBURG, DE / ACCESS Newswire / April 29, 2026 / Evotec SE (NASDAQ:EVO; Frankfurt Prime Standard: EVT) will hold a...
New Verana Health AI Agent Boosts Efficiency and Compliance in MIPS Submissions
Agent Claire empowers clinicians to act faster, reduce risk, and improve operational performanceSAN FRANCISCO, April 28, 2026 /PRNewswire/ -- Verana...
Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel
Agreement facilitates flexible, scalable automated industrialized production of rese-cel for many thousands of patients per year at a cost per...
BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson’s Disease ahead of Topline Data in 2Q26, on May 7, 2026
CARSON CITY, Nev., April 27, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company...
Evotec Announces Chief Financial Officer Transition
Paul Hitchin to step down as of April 30, 2026Claire Hinshelwood appointed to CFO role as of May 1, 2026...
Neura Health to Expand Access to Migraine Care via LillyDirect
The virtual neurology clinic also offers comprehensive specialty care for epilepsy, chronic pain, concussion, memory conditions, and more; appointments are...
Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors
SOUTH SAN FRANCISCO, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, announced...
Black Book Research: Croatia Healthcare IT Shifts From Digitization to Execution
New 2026 report finds CEZIH has reached real national scale, with 15 million annual eReferrals, 61 million ePrescriptions, 300,000 daily...
Black Book Research: Croatia Healthcare IT Shifts From Digitization to Execution
New 2026 report finds CEZIH has reached real national scale, with 15 million annual eReferrals, 61 million ePrescriptions, 300,000 daily...
Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting
SAN DIEGO, April 22, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based...
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®
Members of the Society of Interventional Radiology (SIR) and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Represent the...